Arginine as host directed therapy in tuberculosis: insights from modulating arginine metabolism by supplementation and arginase inhibition
Abstract Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a global health challenge. Arginine metabolism is central to immune responses, regulating nitric oxide (NO) production via inducible NO synthase (Nos2) and competing pathways mediated by arginases (Arg1 and Arg2). This s...
Saved in:
| Main Authors: | Qingkui Jiang, Ranjeet Kumar, Yi Zhao, Selvakumar Subbian, Lanbo Shi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioMed Central
2025-03-01
|
| Series: | One Health Advances |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s44280-025-00070-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Homoarginine, the methylene homologue of arginine, as a substrate of human arginine:glycine amidinotransferase and arginases
by: E. S. Alekseevskaya, et al.
Published: (2018-03-01) -
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma
by: Kimberley M. Hanssen, et al.
Published: (2025-08-01) -
The effect of the use of vacuum therapy and instillation of L-arginine in the treatment of purulent wounds on the activity of nitric oxide cycle enzymes
by: T.V. Horodova-Andrieieva, et al.
Published: (2025-03-01) -
The therapeutic potential of pegylated arginase I treatment in glioblastoma
by: Marcus Kwong Lam Fung, et al.
Published: (2025-08-01) -
Mitophagy: A Potential Therapeutic Target for Tuberculosis Immunotherapy
by: Gao S, et al.
Published: (2025-07-01)